P506: ACHIEVEMENT OF MEASURABLE RESIDUAL DISEASE CLEARANCE IS A STRONGER PREDICTOR OF PATIENT OUTCOME THAN TREATMENT INTENSITY IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA. (23rd June 2022) - Bazinet, A.; Kadia, T.; Short, N.; Borthakur, G.; Wang, S.; Loghavi, S.; Jorgensen, J.; Patel, K.; DiNardo, C.; Daver, N.; Alvarado, Y.; Haddad, F.; et al.